029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FUR1502子宫内膜癌组织芯片,附病理分级、TNM和临床分期,75例/150点
点 数150例 数75
行 数10列 数15
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FUR1502
 
子宫内膜癌组织微阵列芯片,包含75例子宫内膜样腺癌,一例两点(同一病人组织在上下两行同一位置点样)
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ute
-Uterus
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIC1)
TISSUE  ARRAYS FUR1502
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
A
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
B
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
C
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
D
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
E
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
F
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
G
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
H
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
I
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
J
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1135FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant*N
A2257FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A3357FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
A4438FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
A5549FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant5*5N
A6647FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant9*9N
A7756FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant3*2.5*1.2N
A8853FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant6*4*4N
A9954FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*2*0.5N
A101050FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant11*10*4N
A111137FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant6*4.5*3N
A121253FUterusEndometrioid adenocarcinoma (sparse)1T1aN0M0IAMalignant9*8*8N
A131368FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant7*4*4N
A141454FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant2*1.5*1N
A151543FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant8*7*6N
B11635FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant*N
B21757FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
B31857FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
B41938FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
B52049FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant5*5N
B62147FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant9*9N
B72256FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant3*2.5*1.2N
B82353FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant6*4*4N
B92454FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*2*0.5N
B102550FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant11*10*4N
B112637FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant6*4.5*3N
B122753FUterusEndometrioid adenocarcinoma (sparse)1T1aN0M0IAMalignant9*8*8N
B132868FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant7*4*4N
B142954FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant2*1.5*1N
B153043FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant8*7*6N
C13149FUterusEndometrioid adenocarcinoma (atypical hyperplasia)*T1aN0M0IAMalignant2.5*1N
C23250FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant4*2N
C33343FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2*2N
C43453FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant9*9*4N
C53537FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant4*3*1.5N
C63633FUterusEndometrioid adenocarcinoma1--2T1bN0M0IBMalignant11*9*4N
C73756FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3.5N
C83870FUterusEndometrioid adenocarcinoma2T1bN1M0IIIC1Malignant6*4*4N
C93952FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2N
C104046FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3.5*2*0.8N
C114161FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant3*2N
C124230FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
C134357FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
C144452FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
C154558FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D14649FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*1N
D24750FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant4*2N
D34843FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2*2N
D44953FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant9*9*4N
D55037FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant4*3*1.5N
D65133FUterusEndometrioid adenocarcinoma1--2T1bN0M0IBMalignant11*9*4N
D75256FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3.5N
D85370FUterusEndometrioid adenocarcinoma2T1bN1M0IIIC1Malignant6*4*4N
D95452FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2N
D105546FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3.5*2*0.8N
D115661FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant3*2N
D125730FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
D135857FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
D145952FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D156058FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
E16146FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
E26274FUterusEndometrioid adenocarcinoma with necrosis2T1bN0M0IBMalignant3*3*2N
E36359FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant8*3*2.5N
E46454FUterusEndometrioid adenocarcinoma (sparse)2T2N0M0IIMalignant2.5*2*1N
E56556FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant6*4.5*1.5N
E66670FUterusEndometrioid adenocarcinoma with necrosis2T2N0M0IIMalignant1.5*4.5*2N
E76752FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2N
E86868FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant8*6*4N
E96954FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant9*5*3N
E107050FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant6*4*2.5N
E117158FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3*3N
E127243FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant7*3*3N
E137379FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant4*3*0.8N
E147460FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*5*3N
E157563FUterusEndometrioid adenocarcinoma with necrosis2--3T3aN0M0IIIAMalignant9*3*2.5N
F17646FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
F27774FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3*3*2N
F37859FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant8*3*2.5N
F47954FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant2.5*2*1N
F58056FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant6*4.5*1.5N
F68170FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant1.5*4.5*2N
F78252FUterusEndometrioid adenocarcinoma with necrosis2T1bN0M0IBMalignant4*3*2N
F88368FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant8*6*4N
F98454FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant9*5*3N
F108550FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant6*4*2.5N
F118658FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3*3N
F128743FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant7*3*3N
F138879FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant4*3*0.8N
F148960FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*5*3N
F159063FUterusEndometrioid adenocarcinoma with necrosis2--3T3aN0M0IIIAMalignant9*3*2.5N
G19158FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant10*9*7N
G29252FUterusEndometrioid adenocarcinoma2--3T1bN1M0IIIC1Malignant*N
G39343FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant*N
G49448FUterusEndometrioid adenocarcinoma2--3T1aN0M0IAMalignant*N
G59543FUterusEndometrioid adenocarcinoma2--3T1aN0M0IAMalignant*N
G69642FUterusEndometrioid adenocarcinoma2--3T1aN0M0IAMalignant3*2.5*1N
G79753FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant7*6*1.3N
G89858FUterusEndometrioid adenocarcinoma3T3N1M0IIIC1Malignant3*2N
G99945FUterusEndometrioid adenocarcinoma3T1bN1M0IIIC1Malignant*N
G1010054FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant6*4.5*1N
G1110154FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant6*4.5*1N
G1210242FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3.0*1N
G1310348FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant*N
G1410445FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant*N
G1510538FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant5*4*3N
H110658FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant10*9*7N
H210752FUterusEndometrioid adenocarcinoma2--3T1bN1M0IIIC1Malignant*N
H310843FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant*N
H410948FUterusEndometrioid adenocarcinoma with squamous metaplasia2--3T1aN0M0IAMalignant*N
H511043FUterusEndometrioid adenocarcinoma (necrosis)*T1aN0M0IAMalignant*N
H611142FUterusEndometrioid adenocarcinoma2--3T1aN0M0IAMalignant3*2.5*1N
H711253FUterusEndometrioid adenocarcinoma (sparse)2--3T1bN0M0IBMalignant7*6*1.3N
H811358FUterusEndometrioid adenocarcinoma3T3N1M0IIIC1Malignant3*2N
H911445FUterusEndometrioid adenocarcinoma3T1bN1M0IIIC1Malignant*N
H1011554FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant6*4.5*1N
H1111654FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant6*4.5*1N
H1211742FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3.0*1N
H1311848FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant*N
H1411945FUterusEndometrioid adenocarcinoma (interstitial)*T1aN0M0IAMalignant*N
H1512038FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant5*4*3N
I112164FUterusEndometrioid adenocarcinoma with necrosis3T1aN0M0IAMalignant4*4N
I212262FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3*2*1N
I312349FUterusEndometrioid adenocarcinoma3T2N0M0IIMalignant5*5*4N
I412453FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant7*6*4N
I512560FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant4*3*2.5N
I612651FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant8*4.5*4.5N
I712751FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant4*3N
I812853FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant4*2.5*1.5N
I912962FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*1.2N
I1013043FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*2.5N
I1113166FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant*N
I1213263FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*N
I1313355FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant*N
I1413452FUterusEndometrioid adenocarcinoma with necrosis3T2bN0M0IIBMalignant*N
I1513535FUterusEndometrioid adenocarcinoma3--4T3aN0M0IIIAMalignant*N
J113664FUterusEndometrioid adenocarcinoma with necrosis3T1aN0M0IAMalignant4*4N
J213762FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3*2*1N
J313849FUterusEndometrioid adenocarcinoma3T2N0M0IIMalignant5*5*4N
J413953FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant7*6*4N
J514060FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant4*3*2.5N
J614151FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant8*4.5*4.5N
J714251FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant4*3N
J814353FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant4*2.5*1.5N
J914462FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*1.2N
J1014543FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*2.5N
J1114666FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant*N
J1214763FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*N
J1314855FUterusEndometrioid adenocarcinoma (degeneration and necrosis)*T1bN0M0IBMalignant*N
J1414952FUterusEndometrioid adenocarcinoma with necrosis3T2bN0M0IIBMalignant*N
J1515035FUterusEndometrioid adenocarcinoma3--4T3aN0M0IIIAMalignant*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情